Stocks To Buy: UBS bets on two Midcap IT shares for revenue recovery, growth prospects

UBS said the Persistent System’s current valuation (around 44x 1 year forward price-to earnings) price in flattish margins and a 14-15% revenue CAGR, which, according to UBS, appears pessimistic. 

Leave a Reply

Your email address will not be published. Required fields are marked *